When biotech investor Flagship Pioneering announced that it had hired former Food and Drug Administration Commissioner Stephen Hahn, more than a few eyebrows rose.
“It would not be a good look for our industry if the person who approved the vaccine went to work for an affiliated company,” tweeted Brad Loncar, a respected investor. “That would be a TERRIBLE look for both him and Flagship,” one biotech editor tweeted.
Flagship Pioneering is the firm that spawned Moderna, the biotechnology company that developed one of the Covid-19 vaccines that Hahn’s FDA authorized last fall; Flagship Pioneering founder Noubar Afeyan still chairs Moderna’s board.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect